Arbutus Biopharma
ABUS
#7051
Rank
A$0.93 B
Marketcap
A$6.07
Share price
-1.23%
Change (1 day)
-8.99%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): A$0.22 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are A$0.18 Billion. In 2025 the company made an earning of -A$50.62 Million, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.22 B-535.55%
2025 -A$50.62 Million-52.09%
2024 -A$0.11 Billion-4.02%
2023 -A$0.12 Billion12.05%
2022 -A$98.23 Million-14.74%
2021 -A$0.12 Billion19.61%
2020 -A$96.31 Million-61.69%
2019 -A$0.26 Billion171.23%
2018 -A$92.68 Million-43.58%
2017 -A$0.17 Billion-77.77%
2016 -A$0.74 Billion532.77%
2015 -A$0.12 Billion99.05%
2014 -A$58.68 Million175.82%
2013 -A$21.28 Million-143.7%
2012 A$48.68 M-399.11%
2011 -A$16.28 Million-39.03%
2010 -A$26.7 Million100.55%
2009 -A$13.32 Million-28.56%
2008 -A$18.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.27 Million-101.41% Bahamas
NRC Health
NRC
A$22.34 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA